Compugen
Computationally discovered immuno-oncology therapeutic candidates.
Compugen manufactures computationally discovered immuno-oncology therapeutic candidates from its Holon operations. The company supplies healthcare systems, laboratories, OEM partners or regulated export customers across its listed primary markets.
- Type
- Manufacturer
- Location
- Holon, Israel
- Founded
- 1993
- Website
- compugen.co.il
- Categories
- Medical & Healthcare Supplies
- Markets
- Israel, United States, Germany, Japan
Verified facts
- sanctions-clear (green), checked 2026-08-12 OpenSanctions
- debarment-clear (green), checked 2026-08-12 OpenSanctions
Claimed certifications
- Good Manufacturing Practice
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)